Systems and methods for determining nucleic acids

US2025066765A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025066765-A1
Application numberUS-202418932378-A
CountryUS
Kind codeA1
Filing dateOct 30, 2024
Priority dateJul 30, 2014
Publication dateFeb 27, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention generally relates to systems and methods for imaging or determining nucleic acids, for instance, within cells. In some embodiments, the transcriptome of a cell may be determined. Certain embodiments are directed to determining nucleic acids, such as mRNA, within cells at relatively high resolutions. In some embodiments, a plurality of nucleic acid probes may be applied to a sample, and their binding within the sample determined, e.g., using fluorescence, to determine locations of the nucleic acid probes within the sample. In some embodiments, codewords may be based on the binding of the plurality of nucleic acid probes, and in some cases, the codewords may define an error-correcting code to reduce or prevent misidentification of the nucleic acids. In certain cases, a relatively large number of different targets may be identified using a relatively small number of labels, e.g., by using various combinatorial approaches.

First claim

Opening claim text (preview).

1 - 176 . (canceled) 177 . A method for determining a plurality of nucleic acid targets within a sample by in situ hybridization, comprising: (a) contacting a sample comprising a plurality of nucleic acid targets with a plurality of primary nucleic acid probes, wherein each primary nucleic acid probe comprises (i) a target sequence and (ii) one or more read sequences, wherein the target sequence hybridizes to the nucleic acid target in the sample to form a primary probe-hybridized complex; (b) contacting the sample to a second round of hybridization using a plurality of secondary nucleic acid probes, wherein the secondary nucleic acid probes comprise a first portion that hybridizes to a subset of the read sequences and a second portion comprising a fluorescent label; (c) detecting a fluorescent signal from each of the hybridized secondary nucleic acid probes; (d) removing the secondary nucleic acid probes or inactivating the fluorescent signal; and (e) repeating steps (b) through (d) with multiple sets of differing secondary nucleic acid probes to generate a pattern of binding of the secondary nucleic acid probes; wherein the pattern of binding of the secondary nucleic acid probes is converted to a codeword, wherein the codeword determines the identity of the nucleic acid target, and wherein the codeword facilitates error correction. 178 . The method of claim 177 , wherein the target sequence of the plurality of primary nucleic acid probes comprises an average length of between 10 and 195 nucleotides. 179 . The method of claim 177 , wherein the nucleic acid target is RNA. 180 . The method of claim 179 , wherein the method comprises determining the transcriptome of a cell. 181 . The method of claim 180 , wherein at least 25% of the transcriptome is determined. 182 . The method of claim 177 , wherein the plurality of primary nucleic acid probes comprises at least 10 different primary nucleic acid probes. 183 . The method of claim 177 , wherein the codeword comprises N-positions and wherein less than all possible codewords are used to identify the plurality of nucleic acid targets. 184 . The method of claim 177 , wherein each set of the plurality of secondary nucleic acid probes hybridizes to a subset of the read sequences. 185 . The method of claim 177 , wherein the one or more read sequences have an average length of at least 15 nucleotides. 186 . The method of claim 177 , wherein the fluorescent signal is inactivated by photobleaching. 187 . The method of claim 177 , wherein the fluorescent signal is inactivated by removal of the hybridized secondary nucleic acid probe or by chemically or enzymatically cleaving the fluorescent label from the hybridized secondary nucleic acid probe. 188 . The method of claim 177 , wherein the fluorescent signal is detected using a fluorescence imaging technique. 189 . The method of claim 177 , wherein the one or more read sequences are distributed on the plurality of primary nucleic acid probes so as to define an error-correcting code. 190 . The method of claim 177 , wherein if the pattern of binding of the secondary nucleic acid probes identifies a codeword that does not match a valid codeword, the codeword is discarded or matched to form a valid codeword. 191 . The method of claim 177 , wherein the error correction comprises a Hamming system, a Golay code, a SECDED (single error correction, double error detection) system or an extended Hamming system. 192 . The method of claim 177 , wherein the error correction identifies the location of an error. 193 . The method of claim 177 , wherein the error correction identifies a single bit error. 194 . The method of claim 177 , wherein the error correction identifies a two bit error. 195 . The method of claim 177 , wherein the error correction corrects a single bit error. 196 . The method of claim 195 , wherein the plurality of primary nucleic acid probes defines a code space with a Hamming distance of at least 2. 197 . The method of claim 177 , wherein each codeword comprises at least a 14 bit code. 198 . The method of claim 177 , wherein the binding pattern of secondary nucleic acid probes is used to determine location of the nucleic acid targets within the sample. 199 . The method of claim 177 , wherein a given set of differing secondary nucleic acid probes has differing fluorescent labels. 200 . The method of claim 177 , wherein multiple sets of differing secondary nucleic acid probes have the same fluorescent label. 201 . The method of claim 177 , wherein presence of the fluorescent signal is assigned a value in the codeword. 202 . The method of claim 177 , wherein absence of the fluorescent signal is assigned a value in the codeword. 203 . The method of claim 177 , wherein the determining of the plurality of nucleic acid targets within the sample is qualitative and/or quantitative. 204 . The method of claim 177 , wherein the determining of the plurality of nucleic acid targets within the sample is spatial. 205 . The method of claim 177 , wherein the identity of the nucleic acid target within the sample is determined in at least 2 dimensions. 206 . The method of claim 177 , wherein the identity of the nucleic acid target within the sample is determined in at least 3 dimensions.

Assignees

Inventors

Classifications

  • using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title

  • Analysis or design of chemical reactions, syntheses or processes · CPC title

  • Probabilistic graphical models, e.g. probabilistic networks · CPC title

  • Signal processing, e.g. from mass spectrometry [MS] or from PCR · CPC title

  • Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025066765A1 cover?
The present invention generally relates to systems and methods for imaging or determining nucleic acids, for instance, within cells. In some embodiments, the transcriptome of a cell may be determined. Certain embodiments are directed to determining nucleic acids, such as mRNA, within cells at relatively high resolutions. In some embodiments, a plurality of nucleic acid probes may be applied to …
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C12N15/1065. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Feb 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).